Last reviewed 2026-05-13 · How we verify

rosuvastatin only

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Headache
• Sars-cov-2 test positive
• Myalgia
• Arthralgia
• Nasopharyngitis
• Influenza
• Pain in extremity
• Cough
• Fatigue
• Back pain
• Muscle spasms
• Diarrhoea

Key clinical trials

• Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib (PHASE1)
• A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) (PHASE1)
• TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men (PHASE2)
• Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants (PHASE1)
• A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants (PHASE1)
• A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
• A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants (PHASE1)
• A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• rosuvastatin only CI brief — competitive landscape report
• rosuvastatin only updates RSS · CI watch RSS
• LG Life Sciences portfolio CI